These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 21568877

  • 1. Computer-aided design, synthesis, and biological activity evaluation of potent fusion inhibitors targeting HIV-1 gp41.
    Tan JJ, Zhang B, Cong XJ, Yang LF, Liu B, Kong R, Kui ZY, Wang CX, Hu LM.
    Med Chem; 2011 Jul; 7(4):309-16. PubMed ID: 21568877
    [Abstract] [Full Text] [Related]

  • 2. Structure-based design, synthesis and biological evaluation of new N-carboxyphenylpyrrole derivatives as HIV fusion inhibitors targeting gp41.
    Wang Y, Lu H, Zhu Q, Jiang S, Liao Y.
    Bioorg Med Chem Lett; 2010 Jan 01; 20(1):189-92. PubMed ID: 19932616
    [Abstract] [Full Text] [Related]

  • 3. Small molecule fusion inhibitors: design, synthesis and biological evaluation of (Z)-3-(5-(3-benzyl-4-oxo-2-thioxothiazolidinylidene)methyl)-N-(3-carboxy-4-hydroxy)phenyl-2,5-dimethylpyrroles and related derivatives targeting HIV-1 gp41.
    He XY, Lu L, Qiu J, Zou P, Yu F, Jiang XK, Li L, Jiang S, Liu S, Xie L.
    Bioorg Med Chem; 2013 Dec 01; 21(23):7539-48. PubMed ID: 23673219
    [Abstract] [Full Text] [Related]

  • 4. Design, synthesis, and evaluation of indole compounds as novel inhibitors targeting Gp41.
    Zhou G, Wu D, Hermel E, Balogh E, Gochin M.
    Bioorg Med Chem Lett; 2010 Mar 01; 20(5):1500-3. PubMed ID: 20153190
    [Abstract] [Full Text] [Related]

  • 5. Design, synthesis, and biological activity of a novel series of 2,5-disubstituted furans/pyrroles as HIV-1 fusion inhibitors targeting gp41.
    Jiang S, Tala SR, Lu H, Zou P, Avan I, Ibrahim TS, Abo-Dya NE, Abdelmajeid A, Debnath AK, Katritzky AR.
    Bioorg Med Chem Lett; 2011 Nov 15; 21(22):6895-8. PubMed ID: 21978673
    [Abstract] [Full Text] [Related]

  • 6. Peptide and non-peptide HIV fusion inhibitors.
    Jiang S, Zhao Q, Debnath AK.
    Curr Pharm Des; 2002 Nov 15; 8(8):563-80. PubMed ID: 11945159
    [Abstract] [Full Text] [Related]

  • 7. [The current progress in the development of HIV-1 fusion inhibitors].
    Shi WG, Jia QY, Liu KL.
    Yao Xue Xue Bao; 2010 Feb 15; 45(2):184-93. PubMed ID: 21351428
    [Abstract] [Full Text] [Related]

  • 8. N-substituted pyrrole derivatives as novel human immunodeficiency virus type 1 entry inhibitors that interfere with the gp41 six-helix bundle formation and block virus fusion.
    Jiang S, Lu H, Liu S, Zhao Q, He Y, Debnath AK.
    Antimicrob Agents Chemother; 2004 Nov 15; 48(11):4349-59. PubMed ID: 15504864
    [Abstract] [Full Text] [Related]

  • 9. Design, synthesis and biological evaluation of 3-substituted 2,5-dimethyl-N-(3-(1H-tetrazol-5-yl)phenyl)pyrroles as novel potential HIV-1 gp41 inhibitors.
    He XY, Zou P, Qiu J, Hou L, Jiang S, Liu S, Xie L.
    Bioorg Med Chem; 2011 Nov 15; 19(22):6726-34. PubMed ID: 22014749
    [Abstract] [Full Text] [Related]

  • 10. Suitable fusion of N-terminal heptad repeats to achieve covalently stabilized potent N-peptide inhibitors of HIV-1 infection.
    Lai W, Wang C, Yan J, Liu H, Zhang W, Lin B, Xi Z.
    Bioorg Med Chem; 2020 Feb 15; 28(4):115214. PubMed ID: 31932193
    [Abstract] [Full Text] [Related]

  • 11. Design, synthesis, and biological evaluation of N-carboxyphenylpyrrole derivatives as potent HIV fusion inhibitors targeting gp41.
    Liu K, Lu H, Hou L, Qi Z, Teixeira C, Barbault F, Fan BT, Liu S, Jiang S, Xie L.
    J Med Chem; 2008 Dec 25; 51(24):7843-54. PubMed ID: 19053778
    [Abstract] [Full Text] [Related]

  • 12. An effective conjugation strategy for designing short peptide-based HIV-1 fusion inhibitors.
    Liang G, Wang H, Chong H, Cheng S, Jiang X, He Y, Wang C, Liu K.
    Org Biomol Chem; 2016 Aug 16; 14(33):7875-82. PubMed ID: 27454320
    [Abstract] [Full Text] [Related]

  • 13. Development of HIV-1 fusion inhibitors targeting gp41.
    Lu K, Asyifah MR, Shao F, Zhang D.
    Curr Med Chem; 2014 Jun 16; 21(17):1976-96. PubMed ID: 24350848
    [Abstract] [Full Text] [Related]

  • 14. Development of Small-molecule HIV Entry Inhibitors Specifically Targeting gp120 or gp41.
    Lu L, Yu F, Cai L, Debnath AK, Jiang S.
    Curr Top Med Chem; 2016 Jun 16; 16(10):1074-90. PubMed ID: 26324044
    [Abstract] [Full Text] [Related]

  • 15. HIV-1 gp41 fusion intermediate: a target for HIV therapeutics.
    Pan C, Liu S, Jiang S.
    J Formos Med Assoc; 2010 Feb 16; 109(2):94-105. PubMed ID: 20206833
    [Abstract] [Full Text] [Related]

  • 16. Design, synthesis, and biological activity of novel 5-((arylfuran/1H-pyrrol-2-yl)methylene)-2-thioxo-3-(3-(trifluoromethyl)phenyl)thiazolidin-4-ones as HIV-1 fusion inhibitors targeting gp41.
    Jiang S, Tala SR, Lu H, Abo-Dya NE, Avan I, Gyanda K, Lu L, Katritzky AR, Debnath AK.
    J Med Chem; 2011 Jan 27; 54(2):572-9. PubMed ID: 21190369
    [Abstract] [Full Text] [Related]

  • 17. Anti-HIV-1 Activity Prediction of Novel Gp41 Inhibitors Using Structure-Based Virtual Screening and Molecular Dynamics Simulation.
    Sepehri S, Saghaie L, Fassihi A.
    Mol Inform; 2017 Mar 27; 36(3):. PubMed ID: 27730744
    [Abstract] [Full Text] [Related]

  • 18. Dimeric C34 Derivatives Linked through Disulfide Bridges as New HIV-1 Fusion Inhibitors.
    Kobayakawa T, Ebihara K, Honda Y, Fujino M, Nomura W, Yamamoto N, Murakami T, Tamamura H.
    Chembiochem; 2019 Aug 16; 20(16):2101-2108. PubMed ID: 31012222
    [Abstract] [Full Text] [Related]

  • 19. Non-peptide entry inhibitors of HIV-1 that target the gp41 coiled coil pocket.
    Stewart KD, Huth JR, Ng TI, McDaniel K, Hutchinson RN, Stoll VS, Mendoza RR, Matayoshi ED, Carrick R, Mo H, Severin J, Walter K, Richardson PL, Barrett LW, Meadows R, Anderson S, Kohlbrenner W, Maring C, Kempf DJ, Molla A, Olejniczak ET.
    Bioorg Med Chem Lett; 2010 Jan 15; 20(2):612-7. PubMed ID: 20004576
    [Abstract] [Full Text] [Related]

  • 20. Structure-activity relationship studies of indole-based compounds as small molecule HIV-1 fusion inhibitors targeting glycoprotein 41.
    Zhou G, Sofiyev V, Kaur H, Snyder BA, Mankowski MK, Hogan PA, Ptak RG, Gochin M.
    J Med Chem; 2014 Jun 26; 57(12):5270-81. PubMed ID: 24856833
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.